A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
Authors
Keywords
BMI, Anti-PD-1/PD-L1, Overweight, Obesity, Cancer, Immunotherapy
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-27
DOI
10.1186/s40425-019-0527-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: a retrospective case-control study
- (2018) Charles Kyung Min Lee et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
- (2018) Fabio Conforti et al. LANCET ONCOLOGY
- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
- (2018) Jennifer L McQuade et al. LANCET ONCOLOGY
- Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis
- (2018) Siddharth Singh et al. PLoS One
- Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer
- (2018) Koji Haratani et al. JAMA Oncology
- Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
- (2018) Georg Richtig et al. PLoS One
- Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment—Analyses from the German clinical RCC-Registry
- (2018) Peter J. Goebell et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade
- (2018) Ziming Wang et al. NATURE MEDICINE
- White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection
- (2017) Seong-Ji Han et al. IMMUNITY
- Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients
- (2017) Valentine Heidelberger et al. INVESTIGATIONAL NEW DRUGS
- Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
- (2017) Shunsuke Teraoka et al. Journal of Thoracic Oncology
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
- (2017) Andrea Botticelli et al. Oncotarget
- Trends in kidney cancer among the elderly in Denmark, 1980–2012
- (2016) Nessn H. Azawi et al. ACTA ONCOLOGICA
- Antibody-Mediated Thyroid Dysfunction During T-cell Checkpoint Blockade in Patients with Non-Small Cell Lung Cancer
- (2016) J.C. Osorio et al. ANNALS OF ONCOLOGY
- Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations
- (2016) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- The Obesity Paradox in Cancer: a Review
- (2016) Hannah Lennon et al. Current Oncology Reports
- The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases
- (2016) Deena Khan et al. Frontiers in Immunology
- Sarcopenia, obesity, and natural killer cell immune senescence in aging: Altered cytokine levels as a common mechanism
- (2016) Charles T. Lutz et al. Aging-US
- Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
- (2015) M. Freeman-Keller et al. CLINICAL CANCER RESEARCH
- Treatment of Elderly Patients With Non–Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
- (2015) Cesare Gridelli et al. Clinical Lung Cancer
- High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting
- (2015) Sami Antoun et al. EUROPEAN JOURNAL OF CANCER
- Cachexia: clinical features when inflammation drives malnutrition
- (2015) Alessandro Laviano et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
- (2015) Martina Sanlorenzo et al. JAMA Dermatology
- Childhood Obesity: Immune Response and Nutritional Approaches
- (2015) Thea Magrone et al. Frontiers in Immunology
- BMI and Lifetime Changes in BMI and Cancer Mortality Risk
- (2015) Niloofar Taghizadeh et al. PLoS One
- Immune Cell Crosstalk in Obesity: A Key Role for Costimulation?
- (2014) T. Seijkens et al. DIABETES
- Gender Bias in Autoimmunity Is Influenced by Microbiota
- (2013) Leonid Yurkovetskiy et al. IMMUNITY
- Bladder Cancer in Spain 2011: Population Based Study
- (2013) B. Miñana et al. JOURNAL OF UROLOGY
- Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
- (2013) J. G. M. Markle et al. SCIENCE
- Distinctive Features of Melanoma and Its Management in Elderly Patients
- (2013) Dragos Ciocan et al. JAMA Dermatology
- Tissue physiology and pathology of aromatase
- (2011) Carlos Stocco STEROIDS
- Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance
- (2008) Lindsey N. Sutherland et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started